U.S. Pharma Stock News

If you are looking at JetBlue Airways and wondering whether the current share price reflects its true worth, this article will walk through the key numbers that matter for valuation. With the stock at US$4.12 and recent returns of an 8.2% decline over 7 days, a 29.1% decline over 30 days, a 10.2% decline year to date and a 26.4% decline over 1 year, plus a 40.5% decline over 3 years and an 80.4% decline over 5 years, many investors are asking if sentiment has swung too far. These moves sit...

CRISPR Therapeutics (NasdaqGM:CRSP) reports strong commercial progress for its gene editing therapy CASGEVY, with higher than expected revenue contribution. The company highlights a threefold increase in projected patient initiations for 2025, signaling growing real world adoption of CASGEVY. Alongside CASGEVY traction, CRISPR Therapeutics advances new gene editing programs and partnerships, expanding its clinical pipeline. CRISPR Therapeutics, trading at $48.75, is moving further into a...

What is driving interest in Coastal Financial stock? Coastal Financial (CCB) has been in focus after reporting strong net interest income and earnings per share relative to peers, alongside the board appointment of fintech veteran Jeffrey M. Chapman. See our latest analysis for Coastal Financial. Despite the recent headlines, Coastal Financial’s 30-day share price return of 12.22% and 90-day share price return of 32.58% decline show fading near term momentum, while its 3-year and 5-year total...

If you are looking at Everus Construction Group and wondering whether the recent share price makes sense, the key question is how that price stacks up against the company’s underlying value. The stock last closed at US$112.60, with returns of 2.1% over 7 days, 9.9% over 30 days, 26.3% year to date, and 195.9% over the past year. This naturally raises questions about how expectations and risks are being priced in. Recent coverage has focused on Everus Construction Group’s role within the...

If you are wondering whether Griffon is starting to look attractively priced after its recent swings, or if the share price already reflects the story, this valuation review is designed to help you frame that question clearly. The stock closed at US$70.82, with a 7 day return of an 8.5% decline, a 30 day return of a 24.6% decline, a year to date return of a 5.6% decline, but a 1 year return of 2.9% and a 3 year return that is very large compared to the starting point. Recent price moves sit...

Driivz, a Vontier (NYSE:VNT) company, has launched an advanced Energy Management System for electric vehicle charging operators. The new EMS is designed to optimize energy flows, support cost control, and improve capacity use across EV charging networks. For Vontier, which focuses on mobility technologies and related services, the Driivz launch fits directly into its push toward smart mobility and energy management solutions. EV charging operators are dealing with higher power needs, grid...

Graco (GGG) is in focus after unveiling its Pulse Mobile fluid management system at CONEXPO 2026, and naming longtime General Motors finance leader Sanjiv Gupta as its next Chief Financial Officer. See our latest analysis for Graco. These product and leadership updates come after a softer 30 day share price return of a 7.26% decline, while the 90 day share price return of 4.83% and 3 year total shareholder return of 35.29% suggest longer term momentum has been stronger than very recent...

In recent months, Roper Technologies reported mixed Q4 2025 results and conservative 2026 guidance, while continuing to deploy about US$3.30 billion on acquisitions and US$1.80 billion on share repurchases in 2025 to support its software-focused portfolio. Management also highlighted more than 25 generative AI initiatives that are already improving customer retention and are being scaled across Roper’s vertical software businesses to reinforce long-term cash flow growth. We’ll now examine...

Quaker Chemical (NYSE:KWR) has involuntarily terminated Senior Vice President and Chief Global Operations Officer Jeffrey Fleck. The departure affects a key executive role responsible for global operations oversight. This change represents a material event for the company’s leadership and operational continuity. Jeffrey Fleck’s exit comes at a time when Quaker Chemical’s share price stands at $118.45 and recent returns have been weak, with the stock down 8.6% over the past week and 33.4%...

If you are wondering whether SIGA Technologies is attractively priced right now, this article will walk through what the current share price might be implying about its value. The stock closed at US$5.26 most recently, with returns showing a 9.3% decline over 7 days, a 20.8% decline over 30 days, a 16.1% decline year to date, but a 4.1% gain over 1 year and a 23.6% gain over 3 years that contrasts with a more modest 5.3% gain over 5 years. Recent price moves are sitting against a broader...

Autodesk recently outlined its past fiscal fourth quarter performance at the Morgan Stanley Technology, Media & Telecom Conference, highlighting strong results across billings, revenue, margins and free cash flow despite macroeconomic uncertainty. The company also detailed a restructuring plan that includes a 7% workforce reduction to redirect resources toward artificial intelligence, cloud capabilities and its Construction Cloud and Fusion platforms, aiming to sharpen its focus on long-term...

Plexus recently reported a strong quarter with revenues of US$1.07 billion, up 9.6% year on year and in line with analyst expectations, while also exceeding forecasts for earnings per share and issuing higher-than-expected revenue guidance for the next quarter. Management highlighted especially strong momentum in Healthcare/Life Sciences and Aerospace/Defense, underscoring how its investments in talent, technology, and advanced capabilities are reinforcing these higher-complexity,...

A shareholder activist has filed a proposal for West Pharmaceutical Services to permanently separate the CEO and Board Chair roles. The filing coincides with the company’s announcement that CEO and Chair Eric M. Green will retire once a successor is appointed. Investors will vote on the proposal at the upcoming annual meeting, putting corporate governance and board independence in focus. For investors watching NYSE:WST, this governance push comes at a time when the stock has seen mixed...

Director Carol Schneeberger has recently sold shares in Peoples Bancorp. The transactions involved insider stock sales with no corresponding insider purchases reported in the same period. The trades come with Peoples Bancorp shares last closing at $31.6 on the NasdaqGS under ticker NasdaqGS:PEBO. For investors tracking insider activity at Peoples Bancorp, the recent share sale by Director Carol Schneeberger adds a fresh data point to the story around NasdaqGS:PEBO. The stock last closed at...

Curious whether HNI at around US$40.50 is offering you real value today, or if the easy money has already been made? The stock is down about 2.3% over the last week and 21.7% over the last month, yet it still shows a 64.4% return over three years and 16.9% over five years. This contrast can change how investors think about both risk and potential. Recent coverage of HNI has focused on its positioning in commercial services and how investors are reassessing the company in light of changing...

KORU Medical Systems (KRMD) has just posted its FY 2025 third quarter numbers, with revenue of about US$10.4 million and a basic EPS loss of roughly US$0.02, underscoring that the company is still in the red. The company has seen revenue move from about US$8.2 million in Q3 FY 2024 to US$10.4 million in Q3 FY 2025, while quarterly basic EPS has ranged between a loss of roughly US$0.03 and US$0.02 over that period. As a result, investors are likely to focus on how quickly margins can tighten...

Recent performance snapshot Zurn Elkay Water Solutions (ZWS) has drawn attention after a period of mixed share performance, with the stock showing negative moves over the past week, month, past 3 months, and year to date, alongside a positive 1 year total return. See our latest analysis for Zurn Elkay Water Solutions. At a share price of US$45.73, Zurn Elkay Water Solutions has seen short term momentum fade, with a 1 month share price return decline of 11.29%. However, its 1 year total...

If you are wondering whether Daqo New Energy is priced attractively today, the key question is how its current share price lines up with its underlying business value. The stock last closed at US$23.11, with returns of 4.3% over 7 days, a 10.5% decline over 30 days, a 22.1% decline year to date, and a 21.2% gain over 1 year that sits against much weaker 3 year and 5 year returns of 49.4% and 70.8% declines. Recent price moves have been shaped by ongoing sector wide discussion around solar...

If you are wondering whether BrightView Holdings is attractively priced or just a value trap, you are in the right place to unpack what the current share price really reflects. The stock last closed at US$11.81, with returns of 7.2% decline over 7 days, 15.5% decline over 30 days, a 6.3% decline year to date, a 10.9% decline over 1 year, a 102.6% gain over 3 years and a 30.4% decline over 5 years. Taken together, this gives you a mixed picture of how sentiment has shifted over different...

If you are wondering whether Trinity Capital's current share price reflects its true worth, you are not alone. This article is set up to help you look past the headline numbers and into what the valuation actually implies. The stock last closed at US$14.42, with returns of 7.9% over 1 year and much stronger gains over 3 and 5 years. However, the last 7 and 30 days show declines of 3.3% and 8.8% that may have shifted how investors see the balance between opportunity and risk. Recent coverage...

Haemonetics (NYSE:HAE) is expanding its product portfolio in the Hospital division with new technology and acquisitions. The company has fully transitioned from legacy PCS2 plasma collection devices to its NexSys PCS system with Persona Technology. Recent purchases of Attune Medica and OpSens add new capabilities in hospital and interventional cardiology settings. For you as an investor, this shift is about more than one product line. Haemonetics operates across blood management and...

If you are wondering whether Karman Holdings at around US$99.98 is still fairly priced or starting to look stretched, you are not alone. The stock has seen a 25.7% return over the past 30 days, 30.1% year to date, and 201.5% over the last year, with a small 0.6% decline in the most recent 7 days. Recent coverage has focused on Karman Holdings as an evergreen story for investors who want ongoing insight into the stock, with attention on how its share price has moved over different time frames...

Why Sonida Senior Living Is On Investors’ Radar Sonida Senior Living (SNDA) has drawn attention after recent share price swings, with a 1 day return of 4.34% contrasting with a 4.28% decline over the past week. This has prompted closer portfolio reviews. See our latest analysis for Sonida Senior Living. That sharp 1 day share price return of 4.34% comes after a softer 7 day share price return of 4.28%. Sonida Senior Living still has a 90 day share price return of 13.06% and a 1 year total...

If you are wondering whether ACADIA Pharmaceuticals at around US$20.61 is offering good value or just fresh risk, you are in the right place for a closer look at what that price might represent. The share price has seen a 7% decline over the last week, an 8.3% decline over the last month, but a 17.8% return over the last year. This can leave investors questioning whether recent weakness is a setback or a reset after earlier gains. Recent attention on ACADIA has centered on its product...